Pharming Group N.V.
(PHAR)
undefined
undefined%
At close: undefined
8.98
0.00%
After-hours Dec 13, 2024, 03:45 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 |
| Net Income | -9.55M | 14.99M | 22.03M | 47.47M | 68.23M | 43.46M | 26.29M | -12.14M | -9.96M | -5.77M | -15.06M | -24.09M | -17.10M | -56.37M | -32.06M | -26.20M | -35.61M | -18.50M | -21.15M |
| Depreciation & Amortization | 15.93M | 13.19M | 18.72M | 8.95M | 5.80M | 7.50M | 4.10M | 795.09K | - | - | - | - | - | - | - | 1.42M | 1.41M | 1.59M | 1.23M |
| Stock-Based Compensation | 9.25M | 6.39M | 9.06M | 6.54M | 4.44M | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.61M |
| Other Working Capital | 14.27M | 14.63M | 1.14M | 138.98K | 163.54K | -7.16M | 13.80M | 2.54M | - | - | - | - | - | - | - | - | - | 888.23K | 4.45M |
| Other Non-Cash Items | -15.96M | -11.28M | -7.82M | 33.34M | -3.07M | 1.22M | 2.13M | 78.88K | -8.00M | 5.77M | 3.61M | 10.51M | 17.10M | 56.37M | 32.06M | 24.78M | 2.52M | -2.87M | 177.66K |
| Deferred Income Tax | - | - | -721.22K | -2.55M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 52.11K |
| Change in Working Capital | -16.96M | -387.00K | -4.73M | -3.26M | 3.60M | -6.00M | 13.33M | 741.45K | - | - | - | - | - | - | - | - | - | -6.13M | 2.82M |
| Operating Cash Flow | -17.30M | 22.90M | 36.13M | 90.98M | 74.56M | 46.19M | 45.84M | -10.52M | -17.95M | -6.42M | -11.45M | -13.58M | -20.34M | -6.89M | -27.24M | -14.21M | -31.69M | -25.89M | -15.26M |
| Capital Expenditures | -1.46M | -1.98M | -15.96M | -16.47M | -25.44M | -4.31M | -7.25M | -1.59M | -981.79K | -187.27K | -29.00K | -812.02K | -1.37M | -1.21M | -435.56K | -1.13M | -978.32K | -4.16M | -1.02M |
| Acquisitions | - | 7.30M | - | -354.23K | -2.80M | - | - | -58.85M | - | -608.01K | - | - | - | - | - | - | - | -60.71K | - |
| Purchase of Investments | -382.01M | - | -4.38M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -7.11M |
| Sales Maturities Of Investments | 232.81M | - | - | - | - | - | - | - | - | - | - | 722.00K | - | - | 6.46M | - | - | - | 4.69M |
| Other Investing Acitivies | 21.28M | 6.26M | -0.00 | -8.98M | 0.00 | - | - | - | - | - | 361.79K | 232.85K | -51.84K | - | -0.00 | - | - | - | - |
| Investing Cash Flow | -129.39M | 5.32M | -20.34M | -16.82M | -28.25M | -4.31M | -7.25M | -60.45M | -981.79K | -795.27K | 332.79K | 142.83K | -1.42M | -1.21M | 6.02M | -1.13M | -978.32K | -4.22M | -3.43M |
| Debt Repayment | -4.64M | -3.09M | -2.83M | 83.41M | -37.39M | -17.39M | 1.37M | 70.31M | - | - | 14.36M | 9.47M | - | -5.52M | -9.56M | -12.03M | 97.61M | -60.71K | -43.82K |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 3.70M | -4.17M | -29.84M | -25.51M | -26.08M | -12.57M | -4.62M | 496.40K | 15.04M | 18.00M | -2.05M | -1.23M | -701.19K | -1.59M | -121.78K | -14.15M | -15.26M | 15.42M | -0.23 |
| Financial Cash Flow | -941.13K | -4.98M | -26.68M | 65.33M | -62.32M | -20.55M | -3.91M | 70.81M | 15.70M | 21.88M | 29.12M | 15.30M | 16.40M | 17.15M | 3.54M | -26.19M | 84.04M | 45.38M | 10.29M |
| Net Cash Flow | -145.60M | 15.42M | 2.57M | 123.94M | -14.50M | 24.62M | 33.42M | 309.20K | -2.78M | 18.52M | 17.73M | 1.65M | -7.02M | 10.83M | -25.00M | -57.81M | 51.11M | 15.27M | -8.40M |
| Free Cash Flow | -18.77M | 20.92M | 20.17M | 74.51M | 49.11M | 41.87M | 38.59M | -12.11M | -18.94M | -6.61M | -11.48M | -14.39M | -21.71M | -8.09M | -27.68M | -15.35M | -32.67M | -30.05M | -16.28M |